Sean H. Jenkins

Sean H. Jenkins is a procurement professional responsible for managing complex acquisitions in the medical and life sciences sectors, ensuring the agency’s operational needs are met through compliant, efficient contracting practices. He oversees the full lifecycle of procurements—from market research and solicitation development to contract award and administration—with a focus on high-precision medical equipment, diagnostic services, and pharmaceutical production systems. His work directly supports mission-critical healthcare infrastructure, aligning acquisition strategy with regulatory standards and technical specifications required for clinical and laboratory environments. Jenkins collaborates with a diverse range of suppliers, including manufacturers of surgical instruments, pharmaceutical preparers, and specialized medical laboratory service providers. While no single contractor dominates his portfolio, he maintains consistent relationships with firms possessing FDA-regulated manufacturing capabilities, ISO-certified quality systems, and technical expertise in sterile processing and diagnostic instrumentation. His contracting approach emphasizes vendor reliability, supply chain resilience, and adherence to Good Manufacturing Practices, fostering long-term partnerships grounded in performance and compliance. Jenkins consistently prioritizes open competition, with 100% of his acquisitions conducted without set-aside designations. This reflects a strategic preference for broad market engagement over socioeconomic set-asides, ensuring access to the widest possible pool of qualified vendors capable of meeting stringent technical and regulatory requirements. His contracting patterns demonstrate a focus on capability over certification, aligning with agency priorities that demand proven technical performance over socioeconomic categorization. His primary procurement focus centers on NAICS 339112 (Surgical and Medical Instrument Manufacturing), reflecting deep expertise in procuring precision instruments for clinical use. He also regularly acquires products and services under NAICS 325412 (Pharmaceutical Preparation Manufacturing) and 621511 (Medical Laboratories), indicating specialized knowledge in sterile compounding, diagnostic testing infrastructure, and analytical equipment. His domain expertise spans regulatory compliance, sterilization protocols, and quality control standards critical to healthcare delivery systems.